Concepts (167)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Angiotensin II | 6 | 2020 | 601 | 2.51 | Why? |
| Vasoconstrictor Agents | 6 | 2019 | 714 | 1.98 | Why? |
| Shock | 4 | 2019 | 1868 | 1.33 | Why? |
| Hypotension | 3 | 2018 | 392 | 0.83 | Why? |
| Vasodilation | 2 | 2019 | 258 | 0.78 | Why? |
| Anesthesia Department, Hospital | 1 | 2020 | 118 | 0.76 | Why? |
| Butylscopolammonium Bromide | 1 | 2018 | 7 | 0.76 | Why? |
| Monitoring, Physiologic | 3 | 2019 | 1956 | 0.75 | Why? |
| Transurethral Resection of Prostate | 1 | 2018 | 20 | 0.74 | Why? |
| Choristoma | 1 | 2017 | 16 | 0.72 | Why? |
| Shock, Septic | 2 | 2018 | 1313 | 0.71 | Why? |
| Ureter | 1 | 2017 | 59 | 0.69 | Why? |
| Analgesia, Patient-Controlled | 1 | 2016 | 20 | 0.68 | Why? |
| Ureteral Calculi | 1 | 2017 | 78 | 0.66 | Why? |
| Analgesia, Epidural | 1 | 2016 | 63 | 0.63 | Why? |
| Blood Pressure | 2 | 2018 | 2198 | 0.62 | Why? |
| Lactic Acid | 1 | 2019 | 393 | 0.60 | Why? |
| Adrenergic beta-Antagonists | 1 | 2018 | 465 | 0.57 | Why? |
| Postoperative Care | 2 | 2019 | 755 | 0.57 | Why? |
| Heart Injuries | 2 | 2018 | 608 | 0.55 | Why? |
| Pain, Postoperative | 2 | 2019 | 289 | 0.53 | Why? |
| Anesthetics, Local | 1 | 2016 | 205 | 0.53 | Why? |
| Oximetry | 1 | 2018 | 658 | 0.50 | Why? |
| Postoperative Complications | 4 | 2019 | 5861 | 0.49 | Why? |
| Physical Examination | 1 | 2018 | 755 | 0.48 | Why? |
| Urologic Surgical Procedures | 2 | 2018 | 996 | 0.47 | Why? |
| Arthroplasty, Replacement, Knee | 1 | 2016 | 363 | 0.44 | Why? |
| Analgesics, Opioid | 3 | 2019 | 1070 | 0.44 | Why? |
| Carbon Dioxide | 1 | 2018 | 917 | 0.44 | Why? |
| Hemodynamics | 2 | 2018 | 1562 | 0.43 | Why? |
| Delivery of Health Care, Integrated | 1 | 2020 | 1549 | 0.36 | Why? |
| Pain Management | 1 | 2016 | 854 | 0.35 | Why? |
| Ureteral Obstruction | 2 | 2018 | 61 | 0.35 | Why? |
| Urinary Bladder | 2 | 2018 | 170 | 0.33 | Why? |
| Surgical Procedures, Operative | 2 | 2018 | 2662 | 0.30 | Why? |
| Renin-Angiotensin System | 1 | 2020 | 3661 | 0.27 | Why? |
| Atrial Fibrillation | 1 | 2018 | 2320 | 0.27 | Why? |
| Emergency Medical Services | 1 | 2020 | 3557 | 0.26 | Why? |
| Intensive Care Units | 6 | 2022 | 29594 | 0.25 | Why? |
| Respiratory Insufficiency | 3 | 2021 | 7301 | 0.25 | Why? |
| Kidney | 1 | 2017 | 3648 | 0.25 | Why? |
| Double-Blind Method | 3 | 2018 | 5988 | 0.23 | Why? |
| Robotic Surgical Procedures | 2 | 2018 | 787 | 0.20 | Why? |
| Kidney Pelvis | 1 | 2018 | 22 | 0.19 | Why? |
| Cystostomy | 1 | 2018 | 3 | 0.19 | Why? |
| Multicystic Dysplastic Kidney | 1 | 2018 | 5 | 0.19 | Why? |
| Hydrocarbons, Brominated | 1 | 2018 | 21 | 0.19 | Why? |
| Hydronephrosis | 1 | 2018 | 28 | 0.19 | Why? |
| Capnography | 1 | 2018 | 32 | 0.18 | Why? |
| Varicose Veins | 1 | 2018 | 30 | 0.18 | Why? |
| Renin | 1 | 2019 | 167 | 0.18 | Why? |
| Kidney Calculi | 1 | 2018 | 62 | 0.18 | Why? |
| Child, Hospitalized | 1 | 2022 | 556 | 0.18 | Why? |
| Vasopressins | 1 | 2018 | 70 | 0.17 | Why? |
| Cardiac Output | 1 | 2018 | 183 | 0.17 | Why? |
| Bupivacaine | 1 | 2016 | 24 | 0.17 | Why? |
| Catecholamines | 1 | 2017 | 66 | 0.17 | Why? |
| Hypertension, Portal | 1 | 2018 | 73 | 0.17 | Why? |
| Intraabdominal Infections | 1 | 2017 | 90 | 0.16 | Why? |
| Arterial Pressure | 1 | 2018 | 208 | 0.16 | Why? |
| Surgical Flaps | 1 | 2018 | 188 | 0.16 | Why? |
| Delphi Technique | 1 | 2021 | 1257 | 0.16 | Why? |
| Hematuria | 1 | 2018 | 284 | 0.16 | Why? |
| Treatment Outcome | 7 | 2021 | 51732 | 0.15 | Why? |
| Postoperative Period | 1 | 2018 | 651 | 0.15 | Why? |
| Analgesia | 1 | 2018 | 211 | 0.15 | Why? |
| Fentanyl | 1 | 2016 | 142 | 0.14 | Why? |
| Risk Assessment | 2 | 2021 | 25439 | 0.14 | Why? |
| Critical Illness | 1 | 2019 | 17281 | 0.14 | Why? |
| Embolization, Therapeutic | 1 | 2018 | 269 | 0.14 | Why? |
| Blood Pressure Determination | 1 | 2018 | 450 | 0.14 | Why? |
| Osteoarthritis | 1 | 2016 | 205 | 0.14 | Why? |
| Respiratory Rate | 1 | 2018 | 691 | 0.13 | Why? |
| Pain Measurement | 1 | 2016 | 533 | 0.13 | Why? |
| Nausea | 1 | 2016 | 457 | 0.13 | Why? |
| Aspirin | 1 | 2021 | 1043 | 0.12 | Why? |
| Urinary Tract Infections | 1 | 2017 | 534 | 0.11 | Why? |
| Humans | 28 | 2022 | 930598 | 0.11 | Why? |
| Abdominal Pain | 1 | 2017 | 858 | 0.11 | Why? |
| Multicenter Studies as Topic | 1 | 2018 | 2437 | 0.11 | Why? |
| Organ Dysfunction Scores | 1 | 2017 | 1475 | 0.11 | Why? |
| Platelet Aggregation Inhibitors | 1 | 2021 | 1671 | 0.10 | Why? |
| Propensity Score | 1 | 2018 | 2690 | 0.10 | Why? |
| Fibrinolytic Agents | 1 | 2021 | 1702 | 0.10 | Why? |
| Antimicrobial Stewardship | 1 | 2017 | 931 | 0.09 | Why? |
| Heart Rate | 1 | 2018 | 1527 | 0.09 | Why? |
| Recurrence | 1 | 2017 | 3675 | 0.09 | Why? |
| Equipment Design | 1 | 2018 | 3095 | 0.08 | Why? |
| Drug Combinations | 1 | 2016 | 3852 | 0.08 | Why? |
| Drug Therapy, Combination | 2 | 2018 | 7268 | 0.08 | Why? |
| Pharmaceutical Preparations | 1 | 2021 | 1897 | 0.08 | Why? |
| Myocardium | 1 | 2018 | 2323 | 0.08 | Why? |
| Consensus | 1 | 2021 | 6345 | 0.08 | Why? |
| Betacoronavirus | 2 | 2020 | 204454 | 0.08 | Why? |
| Female | 11 | 2022 | 380317 | 0.07 | Why? |
| Anti-Infective Agents | 1 | 2017 | 1766 | 0.07 | Why? |
| Male | 10 | 2022 | 367725 | 0.07 | Why? |
| Amides | 1 | 2016 | 1864 | 0.07 | Why? |
| Middle Aged | 8 | 2021 | 270681 | 0.07 | Why? |
| Receptors, Corticotropin | 1 | 2003 | 1 | 0.07 | Why? |
| Patient Admission | 1 | 2021 | 5250 | 0.07 | Why? |
| Patient Satisfaction | 1 | 2016 | 2517 | 0.07 | Why? |
| Tyrosine | 1 | 2003 | 66 | 0.06 | Why? |
| Aged | 6 | 2021 | 215776 | 0.06 | Why? |
| Prospective Studies | 2 | 2018 | 43301 | 0.06 | Why? |
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2020 | 5277 | 0.06 | Why? |
| Pneumonia, Viral | 2 | 2020 | 243684 | 0.06 | Why? |
| Systemic Inflammatory Response Syndrome | 1 | 2022 | 6653 | 0.06 | Why? |
| Coronavirus Infections | 2 | 2020 | 253789 | 0.06 | Why? |
| Europe | 1 | 2018 | 12702 | 0.05 | Why? |
| Sepsis | 1 | 2018 | 3517 | 0.05 | Why? |
| Hospital Mortality | 3 | 2022 | 22087 | 0.05 | Why? |
| Length of Stay | 1 | 2018 | 11042 | 0.05 | Why? |
| Tissue Adhesives | 1 | 2018 | 6 | 0.05 | Why? |
| Follow-Up Studies | 1 | 2017 | 17020 | 0.05 | Why? |
| Enbucrilate | 1 | 2018 | 7 | 0.05 | Why? |
| Hospitals | 1 | 2018 | 11793 | 0.04 | Why? |
| Liver Cirrhosis, Alcoholic | 1 | 2018 | 32 | 0.04 | Why? |
| Acute Kidney Injury | 1 | 2018 | 5762 | 0.04 | Why? |
| Incidence | 1 | 2018 | 25622 | 0.04 | Why? |
| Injections, Intravenous | 1 | 2017 | 381 | 0.04 | Why? |
| Practice Guidelines as Topic | 1 | 2020 | 15421 | 0.04 | Why? |
| Retrospective Studies | 4 | 2022 | 105322 | 0.04 | Why? |
| Respiration, Artificial | 1 | 2021 | 22116 | 0.04 | Why? |
| Pandemics | 2 | 2020 | 389249 | 0.04 | Why? |
| Biomarkers | 1 | 2019 | 23361 | 0.04 | Why? |
| Adult | 5 | 2021 | 244371 | 0.04 | Why? |
| Prognosis | 1 | 2019 | 32490 | 0.04 | Why? |
| Cohort Studies | 1 | 2018 | 36005 | 0.04 | Why? |
| Tomography, X-Ray Computed | 2 | 2018 | 25144 | 0.03 | Why? |
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2003 | 1454 | 0.03 | Why? |
| Continuous Positive Airway Pressure | 1 | 2021 | 1187 | 0.03 | Why? |
| Morbidity | 1 | 2018 | 1426 | 0.03 | Why? |
| Aged, 80 and over | 2 | 2019 | 88759 | 0.03 | Why? |
| Early Diagnosis | 1 | 2019 | 2443 | 0.03 | Why? |
| Body Mass Index | 1 | 2022 | 4306 | 0.02 | Why? |
| Feasibility Studies | 1 | 2018 | 3467 | 0.02 | Why? |
| Blood Transfusion | 1 | 2018 | 1399 | 0.02 | Why? |
| Logistic Models | 1 | 2022 | 9089 | 0.02 | Why? |
| Young Adult | 1 | 2017 | 93724 | 0.02 | Why? |
| Odds Ratio | 1 | 2018 | 5861 | 0.02 | Why? |
| Antihypertensive Agents | 1 | 2018 | 1962 | 0.02 | Why? |
| Receptors, Melanocortin | 1 | 2003 | 4 | 0.02 | Why? |
| Combinatorial Chemistry Techniques | 1 | 2003 | 54 | 0.02 | Why? |
| Tumor Cells, Cultured | 1 | 2003 | 254 | 0.02 | Why? |
| United States | 2 | 2021 | 46150 | 0.01 | Why? |
| Registries | 1 | 2021 | 12327 | 0.01 | Why? |
| Age Factors | 1 | 2022 | 21039 | 0.01 | Why? |
| Risk Factors | 2 | 2021 | 71621 | 0.01 | Why? |
| Adolescent | 2 | 2022 | 86841 | 0.01 | Why? |
| Infant | 1 | 2022 | 30274 | 0.01 | Why? |
| Lipopolysaccharides | 1 | 2003 | 848 | 0.01 | Why? |
| Time Factors | 1 | 2021 | 31397 | 0.01 | Why? |
| Child, Preschool | 1 | 2022 | 36283 | 0.01 | Why? |
| Comorbidity | 1 | 2022 | 34796 | 0.01 | Why? |
| Structure-Activity Relationship | 1 | 2003 | 2219 | 0.01 | Why? |
| Global Health | 1 | 2017 | 13911 | 0.01 | Why? |
| Tumor Necrosis Factor-alpha | 1 | 2003 | 2483 | 0.01 | Why? |
| Child | 1 | 2022 | 70012 | 0.01 | Why? |
| Mice, Inbred BALB C | 1 | 2003 | 5814 | 0.01 | Why? |
| Lung | 1 | 2021 | 31049 | 0.01 | Why? |
| Acute Disease | 1 | 2003 | 6029 | 0.01 | Why? |
| Surveys and Questionnaires | 1 | 2017 | 43792 | 0.01 | Why? |
| Cross-Sectional Studies | 1 | 2017 | 53120 | 0.01 | Why? |
| Mice | 1 | 2003 | 21357 | 0.00 | Why? |
| Inflammation | 1 | 2003 | 13255 | 0.00 | Why? |
| Animals | 1 | 2003 | 78931 | 0.00 | Why? |
Khanna's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(167)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(196)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_